The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

The FDA previously agreed that together, these studies could constitute two adequate and well-controlled trials to support a potential New Drug Application ... being evaluated for the treatment of wet ...

Pivotal data evaluating the safety and efficacy of the subretinal delivery of ABBV-RGX-314 in patients with wet age-related macular degeneration (wet AMD) are expected ...

It could also help policymakers determine how to allocate funding and regulators to determine the potential benefits of new treatments that aim to slow the progression of the disease.

Each type of diabetes has unique symptoms, causes, and treatments. Learn more about how these types differ from one another. Prediabetes is the term that’s used when your blood sugar is higher ...